Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The three prime untranslated region (3'-UTR) of messenger RNA is the segment that follows the translation termination codon and does not code for protein. It acts as a critical regulatory region, influencing mRNA stability, localization, transport, and translation efficiency. The 3'-UTR contains binding sites for microRNAs and RNA-binding proteins that modulate gene expression post-transcriptionally. These regions can affect how much protein is produced from a transcript, the timing and location of production, and the assembly of protein complexes. The sequence, length, and structure of 3'-UTRs are highly dynamic and contribute to cell type–specific regulation. Aberrant 3'-UTR function or modification is implicated in diverse human diseases, especially cancer, inflammatory, neurodevelopmental, and cardiovascular disorders[1][2][3][4][5][6]. The 3'-UTR is not a conventional therapeutic target like a receptor, enzyme, or transporter. Rather, it is a regulatory RNA element within genes and can be a means to modulate gene expression indirectly via RNA-targeted interventions[2][4]. The entry "Target mRNA 3'-UTR" does not describe a specific molecule, protein, or canonical drug target, but a feature common to many mRNAs. It needs specification to a particular gene for meaningful targeting or structured therapeutic context[1][2][3][4][5].
Not applicable as a canonical therapeutic target. Note: Some therapies (such as antisense oligonucleotides or RNA interference approaches) use complementary sequences to bind or modify the mRNA 3'-UTR of specific genes, affecting their stability or translation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Three prime untranslated region of messenger RNA (3'-UTR of mRNA).